At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 17, 2026 at 17:11 ET
Over the past seven days, key insiders at United Therapeutics, including CEO Martine Rothblatt and CFO James Edgemond, exercised stock options and conducted open-market sales totaling approximately $2.3 million in proceeds. The majority of transactions involved derivative exercises, with over $5.7 million in non-cash option exercises, while actual open-market sales amounted to $1.07 million.
- CEO Martine Rothblatt exercised options for 38,000 shares at $146.03 (total value: $5.57M) and sold 919 shares for $479,625 in open-market transactions.
- CFO James Edgemond exercised options for 10,000 shares at $135.42 (value: $1.35M) and sold 200 shares for $103,657.
- EVP Paul Mahon exercised options for 8,300 shares at $146.03 (value: $1.21M) and sold 753 shares for $397,184.
- Director Judy Olian sold 200 shares for $106,000.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access